Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient enrolled in phase IIb/III study of ifenprodil for treatment of COVID-19

Aug. 7, 2020

AstraZeneca is enrolling participants in phase I study of MEDI-8367

Aug. 7, 2020

SASS6 is involved in the proliferation of esophageal cancer and may be a novel therapeutic target

Aug. 7, 2020

Structure-guided analysis unveils the mechanism of action of a dengue virus 2-specific inhibitor

Aug. 7, 2020

Boehringer Ingelheim initiates first-in-human study of BI-764532

Aug. 7, 2020

New adenosine A2A receptor antagonists discovered by Nuvation Bio

Aug. 7, 2020

Innate Tumor Immunity discloses NLRP3 agonists

Aug. 7, 2020

Chinese researchers identify LPAR1 antagonists

Aug. 7, 2020

Merck & Co. synthesizes HDAC inhibitors

Aug. 7, 2020

Daiichi Sankyo patents new SIRT6 activators

Aug. 7, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...